drugset / Trial / NCT00220480
A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant Depression
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary objective of this multicenter study is to evaluate the efficacy of escitalopram in treatment resistant depression (TRD), assessed by 2 consecutive failed antidepressant treatments from different classes. The last treatment received is a 6 week prospective trial with venlafaxine.
Timeline
- Start
- 2005-02
- Primary completion
- 2011-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Escitalopram | Small molecule | 10 mg | — |
| Subject | Escitalopram | Small molecule | 30 mg | — |